Clinical Trial Update: Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating a biweekly combination of gemcitabine, oxaliplatin, and dexamethasone for relapsed/refractory malignant lymphoma; the cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Decadron (Dexamethasone)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN